Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 1/2014

01-02-2014 | Clinical Investigation

Minimally Invasive Treatment of Giant Haemangiomas of the Liver: Embolisation With Bleomycin

Authors: Halil Bozkaya, Celal Cinar, Fahri Halit Besir, Mustafa Parıldar, Ismail Oran

Published in: CardioVascular and Interventional Radiology | Issue 1/2014

Login to get access

Abstract

Purpose

The management of patients with giant haemangioma of the liver remains controversial. Although the usual treatment method for symptomatic giant haemangioma is surgery, the classical paradigm of operative resection remains. In this study, we evaluated the symptomatic improvement and size-reduction effect of embolisation with bleomycin mixed with lipiodol for the treatment of symptomatic giant hepatic haemangioma.

Methods

This study included 26 patients [21 female, five male; age 41–65 years (mean 49.83 ± 1.53)] with symptomatic giant haemangioma unfit for surgery and treated with selective embolisation by bleomycin mixed with lipiodol. The patients were followed-up (mean 7.4 ± 0.81 months) clinically and using imaging methods. Statistical analysis was performed using SPSS version 16.0, and p < 0.05 was considered to indicate statistical significance.

Results

Embolisation of 32 lesions in 26 patients was performed. The mean volume of the haemangiomas was 446.28 ± 88 cm3 (range 3.39–1559 cm3) before intervention and 244.43 ± 54.38 cm3 (range 94–967 cm3) after intervention. No mortality or morbidity related to the treatment was identified. Symptomatic improvement was observed in all patients, and significant volume reduction was achieved (p = 0.001).

Conclusion

The morbidity of surgical treatment in patients with giant liver hemangioma were similar to those obtained in patients followed-up without treatment. Therefore, follow-up without treatment is preferred in most patients. Thus, minimally invasive embolisation is an alternative and effective treatment for giant symptomatic haemangioma of the liver.
Literature
1.
Choi BY, Nguyen MH (2005) The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 39:401–412PubMedCrossRef
2.
Ishack KG, Rabin L (1975) Benign tumors of the liver. Med Clin North Am 59:995
3.
Pietrabissa A, Giulianotti P, Campatelli A et al (1996) Management and follow-up of 78 giant haemangiomas of the liver. Br J Surg 83:915–918PubMedCrossRef
4.
Weimann A, Ringe B, Klempnauer J et al (1997) Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 21:983–990PubMedCrossRef
5.
Trastec UF, van Heerden JA, Sheedy RF et al (1983) Cavernous hemangiomas of the liver: resect or observe? Am J Surg 145:49–53CrossRef
6.
Schnelldorfer T, Ware AL, Smoot R et al (2010) Management of giant hemangioma of the liver: resection versus observation. J Am Coll Surg 211(6):724–730PubMedCrossRef
7.
Tarazov PG, Polysalov VN, Ryzhkov VK (1990) Hemangiomatosis of the liver and spleen: successful treatment with embolization and spleenectomy. AJR Am J Roentgenol 155:1235–1236PubMedCrossRef
8.
Althaus S, Ashdown B, Coldwell D et al (1996) Transcatheter arterial embolization of two symptomatic giant cavernous hemangiomas of the liver. Cardiovasc Intervent Radiol 19:364–367PubMedCrossRef
9.
Shrivastava DN, Gandhi D, Seith A et al (2001) Trans-catheter arterial embolization in the treatment of symptomatic cavernous hemangiomas of the liver: a prospective study. Abdom Imaging 26:510–514CrossRef
10.
Deutsch GS, Yeh KA, Bates WB III et al (2001) Embolization for management of hepatic hemangiomas. Am Surg 67:159–164PubMed
11.
Giavroglou C, Economou H, Ioannidis I (2003) Arterial embolization of giant hepatic hemangiomas. Cardiovasc Intervent Radiol 26:92–96PubMedCrossRef
12.
Zeng Q, Li Y, Chen Y et al (2004) Gigantic cavernous hemangioma of the liver treated by intra-arterial embolization with pingyangmycin-lipiodol emulsion: a multi-center study. Cardiovasc Intervent Radiol 27(5):481–482PubMedCrossRef
13.
Herman P, Costa ML, Machado MA et al (2005) Management of hepatic hemangiomas: a 14-year experience. J Gastrointest Surg 9:853–859PubMedCrossRef
14.
Erdogan D, Busch OR, van Delden OM et al (2007) Management of liver hemangiomas according to size and symptoms. J Gastroenterol Hepatol 22(11):1953–1958PubMedCrossRef
15.
Ribeiro MAF Jr, Papaiordanou F, Gonçalves JM et al (2010) Spontaneous rupture of hepatic hemangiomas: a review of the literature. World J Hepatol 2(12):428–433CrossRef
16.
Yamamoto T, Kawarada Y, Yano T et al (1991) Spontaneous rupture of hemangioma of the liver: treatment with transcatheter hepatic arterial embolization. Am J Gastroenterol 86:1645–1649PubMed
17.
Chen ZY, Qi QH, Dong ZL (2002) Etiology and management of hemmorrhage in spontaneous liver rupture: a report of 70 cases. World J Gastroenterol 8:1063–1066PubMed
18.
Jain V, Ramachandran V, Garg R et al (2010) Spontaneous rupture of a giant hepatic hemangioma—Sequential management with transcatheter arterial embolization and resection. Saudi J Gastroenterol 16(2):116–119PubMedCentralPubMedCrossRef
19.
Glinkova V, Shevah O, Boaz M et al (2004) Hepatic haemangiomas: possible association with female sex hormones. Gut 53(9):1352–1355PubMedCrossRef
20.
Mungovan JA, Cronan JJ, Vacarro J (1994) Hepatic cavernous hemangiomas: lack of enlargement over time. Radiology 191:111–113PubMed
21.
Yamashita Y, Ogata I, Urata J et al (1997) Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology 203:121–125PubMed
22.
Ho HY, Wu TH, Yu MC et al (2012) Surgical management of giant hepatic hemangiomas: complications and review of the literature. Chang Gung Med J 35(1):70–78PubMed
23.
Brouwers MA, Peeters PM, de Jong KP et al (1997) Surgical treatment of giant haemangioma of the liver. Br J Surg 84:314–316PubMedCrossRef
24.
Billio A, Pescosta N, Rosanelli C et al (2001) Treatment of Kasabach–Merritt syndrome by embolisation of a giant liver hemangioma. Am J Hematol 66:140–141PubMedCrossRef
25.
Malagari K, Alexopoulou E, Dourakis S et al (2007) Transarterial embolization of giant liver hemangiomas associated with Kasabach–Merritt syndrome: a case report. Acta Radiol 48(6):608–612PubMedCrossRef
26.
Soyer P, Levesque M (1995) Hemoperitoneum due to spontaneous rupture of hepatic haemangiomatosis: treatment by superselective arterial embolization and partial hepatectomy. Australas Radiol 39:90–92PubMedCrossRef
27.
Zhao ZR, Li GW, Wang GT (1994) Investigation on blood supply and embolization treatment of cavernous hemangioma of the liver. Chin J Radiol 28:472–475
28.
29.
Oikawa T, Hirotani K, Ogasawara H et al (1990) Inhibition of angiogenesis by bleomycin and its copper complex. Chem Pharm Bull 38:1790–1792PubMedCrossRef
30.
Chen Y, Li Y, Zhu Q et al (2008) Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations.AJR Am J Roentgenol 190(4):966–971PubMedCrossRef
31.
Muir T, Kirstin M, Fourie P et al (2004) Intralesional bleomycin injection for hemangiomas and congenital vascular malformations. Paeditr Surg Int 19:766–773PubMedCrossRef
32.
Duncan IC, Van Der Nest L (2004) Intralesional bleomycin injections for the palliation of epistaxis in hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 25(7):1144–1146PubMed
33.
Ohishi H, Uchida H, Yoshimura H et al (1985) Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 154(1):25–29
34.
Ouyang Y, Ouyang XH, Yu M, Gu SB (2001) Frequency of arterio-venous shunts in hepatic cavernous hemangiomas in adults as seen on selective arteriography and postembolization radiography. Cardiovasc Intervent Radiol 24:161–167PubMedCrossRef
35.
Leung DA, Goin JE, Sickles C et al (2001) Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol 12(3):321–326PubMedCrossRef
Metadata
Title
Minimally Invasive Treatment of Giant Haemangiomas of the Liver: Embolisation With Bleomycin
Authors
Halil Bozkaya
Celal Cinar
Fahri Halit Besir
Mustafa Parıldar
Ismail Oran
Publication date
01-02-2014
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 1/2014
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-013-0618-y

Other articles of this Issue 1/2014

CardioVascular and Interventional Radiology 1/2014 Go to the issue

Clinical Investigation

Use of High-Frequency Jet Ventilation for Percutaneous Tumor Ablation

Clinical Investigation

Comparative Prospective Study of Load Distribution Projection Among Patients with Vertebral Fractures Treated with Percutaneous Vertebroplasty and a Control Group of Healthy Volunteers

Letter to the Editor

Direct Percutaneous Puncture and Embolization of Ruptured Sinus of Valsalva Aneurysm

Clinical Investigation

Impact of Endografting on the Thoracic Aortic Anatomy: Comparative Analysis of the Aortic Geometry before and after the Endograft Implantation

Review

Hepatobiliary Intervention in Children

Technical Note

Percutaneous Intraductal Radiofrequency Ablation for Clearance of Occluded Metal Stent in Malignant Biliary Obstruction: Feasibility and Early Results